Zenicor signs agreement with provider in NHS England
Zenicor has signed an agreement with a primary care provider in the English National Health Service (NHS) regarding the introduction of a more efficient care […]
Zenicor Medical Systems AB has become one of the leading medtech companies in Europe in the fields of early diagnosis of arrhythmias and stroke prevention for health care. Zenicor has developed a unique system, Zenicor-ECG, for early detection and diagnosis of arrhythmias easily and cost-effectively.
Zenicor Medical Systems AB has become one of the leading medtech companies in Europe in the fields of early diagnosis of arrhythmias and stroke prevention for health care. Zenicor has developed a unique system, Zenicor-ECG, for early detection and diagnosis of arrhythmias easily and cost-effectively.
Zenicor Medical Systems AB has become one of the leading medtech companies in Europe in the fields of early diagnosis of arrhythmias and stroke prevention for health care. Zenicor has developed a unique system, Zenicor-ECG, for early detection and diagnosis of arrhythmias easily and cost-effectively.
Zenicor Medical Systems AB has become one of the leading medtech companies in Europe in the fields of early diagnosis of arrhythmias and stroke prevention for health care. Zenicor has developed a unique system, Zenicor-ECG, for early detection and diagnosis of arrhythmias easily and cost-effectively.
In a project from Queen Alexandra Hospital, Portsmouth Hospital NHS trust, UK, 71 Stroke and TIA patients were investigated for Paroxysmal Atrial Fibrillation (PAF), using Zenicor thumb-ECG for 3 weeks in combination with continuous 24 hours Holter ECG. With Zenicor thumb-ECG 14 % of the patients were diagnosed with PAF, but only 7 % were detected with the Holter ECG.
The advantage of Zenicor-ECG is its simplicity. It\’s non invasive and there\’s no need for fixed chest electrodes. The patient can easily take Zenicor-ECG with them to school or sports activities.
After a hospital visit, the patient takes the device home with them for as long an investigation period as is necessary – sometimes several months.
The simplicity and convenience for the patient means that the investigation with Zenicor-ECG can be performed during a longer time period which gives an effective diagnosis without generating loads of data that need analysing.
Zenicor has signed an agreement with a primary care provider in the English National Health Service (NHS) regarding the introduction of a more efficient care […]
Daiichi-Sankyo UK Ltd and Zenicor Medical Systems AB has entered an agreement where Daiichi-Sankyo part-funds a pilot project in which we introduce a new care […]
There are no events in the calendar at the moment